BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 10602374)

  • 1. Gene manipulation in the induction of anti-tumour immunity.
    O'Donnell D; Patel P; Reis e Sousa C
    Gene Ther; 1999 Nov; 6(11):1796-7. PubMed ID: 10602374
    [No Abstract]   [Full Text] [Related]  

  • 2. Targeting gene therapy--a reality?
    Dranoff G
    Mol Ther; 2000 Feb; 1(2):117-8. PubMed ID: 10933921
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutic antibody gene transfer.
    Marasco WA
    Nat Biotechnol; 2005 May; 23(5):551-2. PubMed ID: 15877069
    [No Abstract]   [Full Text] [Related]  

  • 4. Prodrugs for antibody- and gene-directed enzyme prodrug therapies (ADEPT and GDEPT).
    Niculescu-Duvaz I; Friedlos F; Niculescu-Duvaz D; Davies L; Springer CJ
    Anticancer Drug Des; 1999 Dec; 14(6):517-38. PubMed ID: 10834273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stable expression of chimeric anti-CD3 receptors on mammalian cells for stimulation of antitumor immunity.
    Liao KW; Chen BM; Liu TB; Tzou SC; Lin YM; Lin KF; Su CI; Roffler SR
    Cancer Gene Ther; 2003 Oct; 10(10):779-90. PubMed ID: 14502231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Progress in immunology. Therapeutic aspects in clinical medicine].
    Wirth W
    Med Welt; 1982 Dec; 33(51-52):1859-60. PubMed ID: 7162406
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cancer immunotherapy targeting WT1 product which overexpressess in various kinds of malignant neoplasms].
    Oka Y; Tsuboi A; Sugiyama H
    Tanpakushitsu Kakusan Koso; 2003 Aug; 48(11 Suppl):1663-70. PubMed ID: 12931627
    [No Abstract]   [Full Text] [Related]  

  • 8. Minimal residual disease as the target for immunotherapy and gene therapy of cancer (review).
    Bubeník J; Símová J
    Oncol Rep; 2005 Nov; 14(5):1377-80. PubMed ID: 16211312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic approaches to the diagnosis and treatment of malignant disease.
    Coral FS
    NITA; 1982; 5(4):256-61. PubMed ID: 6750451
    [No Abstract]   [Full Text] [Related]  

  • 10. A "friendly merger" in the war on cancer.
    Sadelain M
    Mol Ther; 2000 Feb; 1(2):115-6. PubMed ID: 10933920
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prospects for improving antibody therapy for carcinoma].
    Liu XY
    Zhonghua Yi Xue Za Zhi; 2004 Jul; 84(14):1145-6. PubMed ID: 15387972
    [No Abstract]   [Full Text] [Related]  

  • 12. Genetic adjuvant therapy for pancreatic cancer and other solid tumours.
    Bagley KC
    Gut; 2008 Mar; 57(3):289-91. PubMed ID: 18268052
    [No Abstract]   [Full Text] [Related]  

  • 13. ICP34.5 deleted herpes simplex virus with enhanced oncolytic, immune stimulating, and anti-tumour properties.
    Liu BL; Robinson M; Han ZQ; Branston RH; English C; Reay P; McGrath Y; Thomas SK; Thornton M; Bullock P; Love CA; Coffin RS
    Gene Ther; 2003 Feb; 10(4):292-303. PubMed ID: 12595888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of T-helper-1 versus T-helper-2 activity and enhancement of tumor immunity by combined DNA-based vaccination and nonviral cytokine gene transfer.
    Song K; Chang Y; Prud'homme GJ
    Gene Ther; 2000 Mar; 7(6):481-92. PubMed ID: 10757021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current trends in the biological therapy of malignant tumors].
    Khanson KP; Afanas'ev BV; Bershteĭn LM; Blinov NN; Gershanovich ML; Imianitov EN; Moiseenko VM; Okulov VB; Togo AV
    Vopr Onkol; 1996; 42(5):7-12. PubMed ID: 9064908
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemotherapy and immunotherapy of tumours induced by gene-modified HPV16-transformed cells.
    Sobotková E; Dusková M; Smahel M; Holán V; Janousková O; Vonka V
    Oncol Rep; 2004 Oct; 12(4):877-83. PubMed ID: 15375516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy of cancer: induction of anti-tumor immunity.
    Qian C; Prieto J
    Cell Mol Immunol; 2004 Apr; 1(2):105-11. PubMed ID: 16212896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Taking lessons from dendritic cells: multiple xenogeneic ligands for leukocyte integrins have the potential to stimulate anti-tumor immunity.
    Kanwar J; Berg R; Lehnert K; Krissansen G
    Gene Ther; 1999 Nov; 6(11):1835-44. PubMed ID: 10602379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological therapy in cancer.
    Idowu OE
    Niger J Med; 2001; 10(3):102-5. PubMed ID: 11806006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer gene therapy steadily advances.
    Brower V
    J Natl Cancer Inst; 2008 Sep; 100(18):1276-8. PubMed ID: 18780858
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.